MANSFIELD, Mass.--(BUSINESS WIRE)--Jan. 3, 2012--
Covidien (NYSE: COV), a leading global provider of healthcare products,
will present at the 30th Annual J.P. Morgan Healthcare Conference in San
Francisco, California, on January 9, 2012. José E. Almeida, President
and Chief Executive Officer, will discuss the Company in a presentation
scheduled to begin at 11:30AM ET.
A live audio webcast of the presentation can be accessed at Covidien’s
Investor Relations website: http://investor.covidien.com.
An archived edition of the presentation will be available following the
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit http://www.covidien.com
to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343